This public link is valid for 7 days and shares a thread, including any personal information you added. This link or copies made by others cannot be deleted. If you share with third parties, their policies apply. Can’t copy the link right now. Try again later. Mird237 2021
A side-by-side collage of the 2021 and 2024 cover art. Option 3: The "Review" Post (For Collectors) mird237 2021
To understand why the year "2021" is critical, compare the archived data: This public link is valid for 7 days
The 2021 research not only deepened the mechanistic understanding of NAFLD but also opened doors for potential clinical applications. The miR-23-27-24 cluster is considered an "emerging target" for diagnosis and therapy. For instance, hepatocyte-derived exosomal miR-27a was identified as a potential non-invasive biomarker, as its levels in serum were found to be elevated in patients with Metabolic Associated Fatty Liver Disease (MAFLD). Targeting these miRNAs therapeutically—either by inhibiting or reintroducing them—could become a novel strategy to treat NAFLD and its complications. Can’t copy the link right now